EEG Changes and Cognitive Profiles in Sepsis Patients With Different Inflammatory Phenotypes
Key facts
- Who runs it
- Xiangya Hospital of Central South University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 78 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 1 May 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- EEG monitoring
- Record updated
- 12 August 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age ≥18 years and ≤90 years
- First-time admission to the Intensive Care Unit (ICU)
- Diagnosis of sepsis according to Sepsis-3.0 criteria (documented or clinically suspected infection plus Sequential Organ Failure Assessment [SOFA] score ≥2 points)
- Expected ICU survival time ≥24 hours
- Written informed consent provided by the patient or legal surrogate
Who cannot take part
- Pre-existing primary central nervous system (CNS) diseases, including:; Acute cerebrovascular disease (e.g., hemiplegia, cranial nerve palsy) Central nervous system infection (e.g., pleocytosis in cerebrospinal fluid) Organic or metabolic encephalopathy (e.g., hepatic, renal, pulmonary, pancreatic, or severe inherited metabolic disorders) Drug-related encephalopathy (e.g., antipsychotic-associated encephalopathy, serotonin syndrome, neurotoxic antibiotics) Other structural or immunological brain diseases (e.g., traumatic brain injury, intracranial neoplasm, autoimmune encephalopathy)
- Inability to cooperate with or tolerate scalp EEG electrode placement (e.g., extensive scalp trauma or open scalp infection)
- Pregnancy or lactation
- Cardiopulmonary-cerebral resuscitation (CPCR) performed during the current hospital admission
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To characterize the electroencephalogram (EEG) features of sepsis patients with distinct inflammatory response phenotypes, dynamically track their evolutionary trajectories, and analyze their associations with long-term changes in cognitive function.
The 2 groups in the trial
- High Inflammatory Phenotype Group
Septic patients displaying serum Interleukin-6 (IL-6) ≥ 400 pg/mL upon ICU admission (Day 1) .
Treatment: EEG monitoring
- Low Inflammatory Phenotype Group
Septic patients displaying serum Interleukin-6 (IL-6) \< 400 pg/mL upon ICU admission (Day 1) .
Treatment: EEG monitoring
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Electroencephalogram Changes and Cognitive Function Profiles in Sepsis Patients With Different Inflammatory Phenotypes
- Criteria questions
- Built from NCT07760415, who can take part
- Record updated
- 12 August 2026